James Basta - Jan 4, 2023 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
EVP, General Counsel
Signature
James Basta
Stock symbol
NTLA
Transactions as of
Jan 4, 2023
Transactions value $
-$42,345
Form type
4
Date filed
1/6/2023, 04:19 PM
Previous filing
Mar 4, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$42.3K -1.14K -5.5% $37.21 19.6K Jan 4, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.